Vaz Nery, Susana
Qi, Jessica
Llewellyn, Stacey
Clarke, Naomi E.
Traub, Rebecca
Gray, Darren J.
Vallely, Andrew J.
Williams, Gail M.
Andrews, Ross M.
McCarthy, James S.
Clements, Archie C. A.
Funding for this research was provided by:
National Health and Medical Research Council
Australian Government Research Training Program Scholarship
Article History
Received: 2 October 2017
Accepted: 9 April 2018
First Online: 28 June 2018
Ethics approval and consent to participate
: This study was approved by the Human Research Ethics Committees at: The University of Queensland (2011000734), Australian National University (2014/311) and the Timorese Ministry of Health (2011/51). Written consent was obtained from all participants aged 18 years or older, and from parents or guardians for those younger than 18 years. Participants aged 12–17 years provided written assent. Consenting individuals were given a single 400 mg dose of albendazole after stool collection. Drug distribution was done by trained field workers. Children aged under 2 years were given half the dose.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.